School of Biomedical Science, Institute of Clinical Sciences, College of Medical and Dental Sciences, University of Birmingham, B15 2TT, United Kingdom.
Institute of Cardiovascular Science, College of Medical and Dental Sciences, University of Birmingham, B15 2TT, United Kingdom; Department of Cardiology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom.
Auton Neurosci. 2020 Jan;223:102611. doi: 10.1016/j.autneu.2019.102611. Epub 2019 Dec 26.
Here, we validate the use of a novel fluorescent norepinephrine transporter (NET) substrate for dynamic measurements of transporter function in rodent cardiovascular tissue; this technique avoids the use of radiotracers and provides single-terminal resolution. Rodent (Wistar rats and C57BL/6 mice) hearts and mesenteric arteries (MA) were isolated, loaded with NET substrate Neurotransmitter Transporter Uptake Assay (NTUA) ex vivo and imaged with confocal microscopy. NTUA labelled noradrenergic nerve terminals in all four chambers of the heart and on the surface of MA. In all tissues, a temperature-dependent, stable linear increase in intra-terminal fluorescence upon NTUA exposure was observed; this was abolished by NET inhibitor desipramine (1 μM) and reversed by indirectly-acting sympathomimetic amine tyramine (10 μM). NET reuptake rates were similar across the mouse cardiac chambers. In both species, cardiac NET activity was significantly greater than in MA (by 62 ± 29% (mouse) and 21 ± 16% (rat)). We also show that mouse NET reuptake rate was twice as fast as that in the rat (for example, in the heart, by 94 ± 30%). Finally, NET reuptake rate in the mouse heart was attenuated with muscarinic agonist carbachol (10 μM) thus demonstrating the potential for parasympathetic regulation of norepinephrine clearance. Our data provide the first demonstration of monitoring intra-terminal NET function in rodent cardiovascular tissue. This straightforward method allows dynamic measurements of transporter rate in response to varying physiological conditions and drug treatments; this offers the potential to study new mechanisms of sympathetic dysfunction associated with cardiovascular disease.
在这里,我们验证了一种新型荧光去甲肾上腺素转运体 (NET) 底物在啮齿动物心血管组织中转运体功能的动态测量中的应用;该技术避免了放射性示踪剂的使用,并提供了单末端分辨率。分离出啮齿动物(Wistar 大鼠和 C57BL/6 小鼠)心脏和肠系膜动脉(MA),用 NET 底物神经递质转运体摄取测定法(NTUA)进行离体负载,并用共聚焦显微镜进行成像。NTUA 标记了心脏四个腔室和 MA 表面的去甲肾上腺素能神经末梢。在所有组织中,观察到 NTUA 暴露后 intra-terminal 荧光的温度依赖性、稳定的线性增加;这被 NET 抑制剂去甲丙咪嗪(1 μM)消除,并被间接作用的拟交感胺酪胺(10 μM)逆转。NET 再摄取率在小鼠心脏各腔室之间相似。在这两种物种中,心脏 NET 活性明显高于 MA(分别为 62±29%(小鼠)和 21±16%(大鼠))。我们还表明,小鼠 NET 再摄取率是大鼠的两倍快(例如,在心脏中,为 94±30%)。最后,M 型乙酰胆碱受体激动剂卡巴胆碱(10 μM)减弱了小鼠心脏中的 NET 再摄取率,从而证明了去甲肾上腺素清除的副交感神经调节的潜力。我们的数据首次证明了在啮齿动物心血管组织中监测 intra-terminal NET 功能。这种简单的方法允许根据不同的生理条件和药物治疗动态测量转运体的速率;这为研究与心血管疾病相关的交感神经功能障碍的新机制提供了潜力。